Oklahoma SB29 requires licensed practitioners to offer pharmacogenomic tests before prescribing psychotropic drugs.
Oklahoma SB29 mandates that licensed practitioners offer pharmacogenomic tests to patients before prescribing psychotropic drugs. The practitioner must inform the patient about the test's efficacy and cost, and obtain informed consent if the patient agrees to the test. The test must be administered before any psychotropic medication is prescribed. The act becomes effective November 1, 2025.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.